糖皮质激素类联合长效β2受体激动剂对56例稳定期COPD患者的疗效影响（预防与卫生学资料）.docVIP

下载本文档

0
0
约9.17千字
约 12页
2022-06-01 发布于广东
举报
版权申诉

糖皮质激素类联合长效β2受体激动剂对56例稳定期COPD患者的疗效影响（预防与卫生学资料）.doc

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

糖皮质激素类联合长效β2受体激动剂对56例稳定期COPD患者的疗效影响（预防与卫生学资料）目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1：糖皮质激素类联合长效β2受体激动剂对56例稳定期COPD患者的疗效影响 1 1 资料与方法 3 2 结果 5 3 讨论 5 文2：长效β2受体激动剂辅助治疗哮喘患者的价值分析 7 1 资料与方法 7 2 结果 8 3 讨论 9 参考文摘引言： 10 原创性声明（模板） 11 文章致谢（模板） 11 正文糖皮质激素类联合长效β2受体激动剂对56例稳定期COPD患者的疗效影响（预防与卫生学资料）文1：糖皮质激素类联合长效β2受体激动剂对56例稳定期COPD患者的疗效影响 Effect of glucocorticoid hormones combined with long acting β2 receptor agonist in the treatment of 56 cases of patients with COPD at stable period* XIA Wu， MEN Li， LIU Hongping （The Hospital affiliated to Jiujiang Univeity， Jiangxi， Jiujiang 332000， China） ABSTRACT Objective： To discuss the effect of glucocorticoid hormones combined with long acting b2 receptor agonist in the treatment of patients with COPD at stable period. Methods： One hundred and eight cases of patients with COPD at stable period were selected and randomly divided into an experimental group （n=56） and a control group （n=52）. The control group was given a conventional therapy and the experimental group was additionally given an inhalation therapy of salmeterol plus fluticasone propionate twice a day for 28 days besides the conventional therapy. The clinical efficacy was evaluated and the pulmonary function and the levels of serum IL-2 and CRP were detected before and after treatment. Results： There was no statistical significance in FEV1， FEV1 / FVC between the two groups before treatment， however these indicato were significantly increased after treatment and furthermore higher in the experimental group than the control group （）， and however， the MMRC was significantly lower and 6 MWT was higher in the experimental group than the control group after treatment （P）. There was no statistical significance in the levels of serum IL-2 and CRP between the two groups before treatment， and the IL-2 and CRP of experimental group were significantly lower than that of control group after treatment （P）. Conclusion： The inhalation therapy of salmeterol plus